Screener
Dogwood Therapeutics DWTX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -64.6%+387pp | —— | -931%-730pp | -494.1%-375pp | -451.3%-334pp | |
| Liquidity | ||||||
| Current ratio | 5.9×-1.6× | 2.8×-2.5× | 4.5×+2.8× | 7.8×+0.5× | 7.4×+1.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×— | 0×— | 0×— | 0×— | |
| Per Share | ||||||
| Book value per share | $2.40-51.1% | $15.05+253% | $3.78+342% | $3.60+5.1% | $4.92+42.7% | |
| Valuation | ||||||
| Market capitalization | $47.93M-74.1% | $123.67M+188% | $228.9M— | $120.16M— | $124.12M— | |
| Price / book | 0.6×-24.7× | 1.7×— | 31.5×— | 17.5×— | 17.5×— |
FAQ
- Where do Dogwood Therapeutics's ratios come from?
- Every ratio is computed from Dogwood Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.